Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and efficacy of prophylactic and therapeutic vaccine based on live-attenuated Listeria monocytogenes in hepatobiliary cancers.
Hochnadel I, Hoenicke L, Petriv N, Neubert L, Reinhard E, Hirsch T, Alfonso JCL, Suo H, Longerich T, Geffers R, Lichtinghagen R, Guzmán CA, Wedemeyer H, Lenzen H, Manns MP, Bruder D, Yevsa T. Hochnadel I, et al. Among authors: petriv n. Oncogene. 2022 Apr;41(14):2039-2053. doi: 10.1038/s41388-022-02222-z. Epub 2022 Feb 16. Oncogene. 2022. PMID: 35173308 Free PMC article.
Correction: Safety and efficacy of prophylactic and therapeutic vaccine based on live-attenuated Listeria monocytogenes in hepatobiliary cancers.
Hochnadel I, Hoenicke L, Petriv N, Neubert L, Reinhard E, Hirsch T, Alfonso JCL, Suo H, Longerich T, Geffers R, Lichtinghagen R, Guzmán CA, Wedemeyer H, Lenzen H, Manns MP, Bruder D, Yevsa T. Hochnadel I, et al. Among authors: petriv n. Oncogene. 2022 May;41(19):2787. doi: 10.1038/s41388-022-02261-6. Oncogene. 2022. PMID: 35418693 Free PMC article. No abstract available.
Increase of α-dicarbonyls in liver and receptor for advanced glycation end products on immune cells are linked to nonalcoholic fatty liver disease and liver cancer.
Petriv N, Neubert L, Vatashchuk M, Timrott K, Suo H, Hochnadel I, Huber R, Petzold C, Hrushchenko A, Yatsenko AS, Shcherbata HR, Wedemeyer H, Lichtinghagen R, Falfushynska H, Lushchak V, Manns MP, Bantel H, Semchyshyn H, Yevsa T. Petriv N, et al. Oncoimmunology. 2021 Feb 8;10(1):1874159. doi: 10.1080/2162402X.2021.1874159. Oncoimmunology. 2021. PMID: 33628620 Free PMC article.
Elucidating the mechanism behind and investigating the efficacy of Traditional Chinese Medicine and Traditional Tibetan Medicine in combination with standard therapeutics in hepatocellular carcinoma and cholangiocarcinoma in vitro.
Suo H, Hochnadel I, Petriv N, Franke R, Schmidt J, Limanska N, Tugai A, Jedicke N, Broenstrup M, Manns MP, Yevsa T. Suo H, et al. Among authors: petriv n. Front Pharmacol. 2022 Sep 12;13:906468. doi: 10.3389/fphar.2022.906468. eCollection 2022. Front Pharmacol. 2022. PMID: 36172191 Free PMC article.
NMDA receptor expression during cell transformation process at early stages of liver cancer in rodent models.
Stepanov YV, Golovynska I, Dziubenko NV, Kuznietsova HM, Petriv N, Skrypkina I, Golovynskyi S, Stepanova LI, Stohnii Y, Garmanchuk LV, Ostapchenko LI, Yevsa T, Qu J, Ohulchanskyy TY. Stepanov YV, et al. Among authors: petriv n. Am J Physiol Gastrointest Liver Physiol. 2022 Jan 1;322(1):G142-G153. doi: 10.1152/ajpgi.00060.2021. Epub 2021 Dec 1. Am J Physiol Gastrointest Liver Physiol. 2022. PMID: 34851733 Free article.